Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
07/2012
07/11/2012CN102100867B Musk rheumatism bone paste
07/11/2012CN102058884B Grass carp injection vaccine synergist and preparation method thereof
07/11/2012CN102058716B Tincture for treating circumscribed neuro dermatitis and preparation method thereof
07/11/2012CN102031220B Spirit-nourishing health-care wine and preparation method thereof
07/11/2012CN102028888B Method for preparing Chinese medicinal composition for treating cold
07/11/2012CN101972372B Medicament for treating hyperlipidaemia and preparation method thereof
07/11/2012CN101869700B Chinese medicinal oral liquid for treating tumour and preparation method thereof
07/11/2012CN101829316B Lactalbumin hydrolysate and application thereof in preparing glucose-lowering medicament
07/11/2012CN101757200B Traditional Chinese medicine composition for treating chronic gastritis and preparation method thereof
07/11/2012CN101721427B Method for preparing gallinaceous Newcastle disease transspecific factor
07/11/2012CN101683437B Traditional Chinese medicine composition for soothing liver and strengthening spleen and nourishing qi and promoting blood circulation and preparation method thereof
07/11/2012CN101683403B Traditional Chinese medicine composition for treating hepatitis B and preparation method thereof
07/11/2012CN101522887B Novel lactic acid bacteria
07/11/2012CN101469322B Cell preparation for liver injury and hepatic cirrhosis and preparation thereof
07/11/2012CN101392218B Nutrient health wine brewed by natural honey and Chinese herbal medicine and preparation method thereof
07/11/2012CN101243187B Method of producing lymphocytes
07/10/2012US8217151 Pasteurisation process for microbial cells and microbial oil
07/10/2012US8217002 Pheromones and the luteinizing hormone for inducing proliferation of neural stem cells and neurogenesis
07/10/2012US8216782 PTTG1 as a biomarker for cancer treatment
07/10/2012US8216605 Moderating the effect of endotoxins
07/10/2012US8216599 Administering hydroxytyrosol and oleuropein in a ratio of 1:1-200:1
07/10/2012US8216587 Method of vaccination
07/10/2012US8216557 Methods of treating skin disease, scalp disease, sensitive skin or suppressing hair loss with microbubble washing compositions
07/10/2012CA2644311C Composition and method for topical treatment of tar-responsive dermatological disorders
07/10/2012CA2516510C Method of using adipose tissue-derived cells in the treatment of cardiovascular conditions
07/10/2012CA2500390C Compositions having an inner core and at least two surrounding layers
07/10/2012CA2486585C Manipulation of the rate of gastrointestinal transit by modulating intestinal methane concentration
07/10/2012CA2477954C Means and methods for the production of adenovirus vectors
07/10/2012CA2477371C Immunostimulatory agent comprising a biomass of methanotrophic bacterium
07/10/2012CA2476730C A photoprotective orally administrable composition for skin
07/10/2012CA2442053C Composition comprising a prebiotic for decreasing inflammatory process and abnormal activation of non-specific immune parameters
07/10/2012CA2368677C Intramyocardial injection of autologous bone marrow
07/10/2012CA2342040C Anaerobic bacterium as a drug for cancer gene therapy
07/10/2012CA2260265C Novel use of phospholipids of animal origin in therapy and/or dietetics
07/05/2012WO2012092603A1 Method for treating pancreatitis mesenchymal stem cells
07/05/2012WO2012092485A1 Enhancement of placental stem cell potency using modulatory rna molecules
07/05/2012WO2012092480A1 Compositions comprising amnion derived adherent cells and platelet-rich plasma
07/05/2012WO2012092458A2 Compositions comprising placental stem cells and platelet rich plasma, and methods of use thereof
07/05/2012WO2012092420A2 Methods for cryopreserving and encapsulating cells
07/05/2012WO2012092155A1 Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota
07/05/2012WO2012091946A2 Method for inhibiting pathogens using a nutritional composition
07/05/2012WO2012091945A1 Use of nutritional compositions including lactoferrin in supporting resistance to diseases and conditions
07/05/2012WO2012091911A1 Ultrasonic cavitation derived stromal or mesenchymal vascular extracts and cells derived therefrom obtained from adipose tissue and use thereof
07/05/2012WO2012091685A1 Thai herb modified traditional drugs
07/05/2012WO2012091683A1 Method for extracting silk extract containing lutein
07/05/2012WO2012091629A1 Use of a lysate of actinomycetins for the preparation of external treatment agents for acne and method for treating acne
07/05/2012WO2012091136A1 Expression vector, method for producing carrier using same, and use of same
07/05/2012WO2012091118A1 Therapeutic agent for ectopic pregnancy
07/05/2012WO2012091081A1 Interferon production-inducing agent containing lactic acid bacteria
07/05/2012WO2012090623A1 Capsule for delivering bifidobacterium into large intestine and method for producing same
07/05/2012WO2012089784A1 Fiber and probiotics for reducing intestinal symptoms related to chronic stress
07/05/2012WO2012089783A1 A nutritional composition comprising fiber and probiotics for reducing stress-related intestinal symptoms
07/05/2012WO2012089782A1 Fiber and probiotics for reducing intestinal symptoms related to stress
07/05/2012WO2012088651A1 Preparation method of deer blood wine
07/05/2012WO2012040408A3 Engineered vascular adipose tissue
07/05/2012US20120172985 Silk fibroin hydrogels and uses thereof
07/05/2012US20120171295 Methods for cryopreserving and encapsulating cells
07/05/2012US20120171256 Electrospun silk material systems for wound healing
07/05/2012US20120171230 Oral vaccines produced and administered using edible micro-organism
07/05/2012US20120171215 Nogo-a binding molecules and pharmaceutical use thereof
07/05/2012US20120171213 Method of treating tumors
07/05/2012US20120171193 Diagnostic and Treatment Methods for Characterizing Bacterial Microbiota in Skin Conditions
07/05/2012US20120171182 Methods and compositions for the treatment, prevention, and alleviation of bone and cartilage diseases or injuries and hair loss
07/05/2012US20120171181 Compositions and minimally invasive methods for treating cancer
07/05/2012US20120171180 Compositions comprising amnion derived adherent cells and platelet-rich plasma
07/05/2012US20120171179 Apparatus, system, and method for compositions and methods for treating, preventing, or alleviating bone or cartilage diseases
07/05/2012US20120171178 Nutritional composition for supporting brain development and function of children
07/05/2012US20120171177 Nutritional composition for supporting brain development and function of toddlers
07/05/2012US20120171176 Use of nutritional compositions including lactoferrin and one or more prebiotics in inhibiting adhesion of pathogens in the gastrointestinal tract
07/05/2012US20120171175 Methods for treating refractory infections in neutropenic individuals
07/05/2012US20120171174 Methods of Inducing Tissue Regeneration
07/05/2012US20120171173 Process for production of natural killer cells
07/05/2012US20120171172 Methods Of Engineering Neural Tissue
07/05/2012US20120171171 Methods and Compositions for In Vitro and In Vivo Chondrogenesis
07/05/2012US20120171170 Treatment of collagen gene related diseases by inhibition of natural antisense transcript to a collagen gene
07/05/2012US20120171169 Compositions and methods for treating, preventing, or alleviating bone or cartilage diseases
07/05/2012US20120171168 Method for treating pancreatitis with mesenchymal stem cells
07/05/2012US20120171167 Anti-obesity agent, anti-obesity food or beverage, glucose tolerance-ameliorating agent, and food or beverage for amelioration of glucose tolerance
07/05/2012US20120171166 Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota
07/05/2012US20120171165 Human milk oligosaccharides to promote growth of beneficial bacteria
07/05/2012US20120171164 Use of nutritional compositions including lactoferrin in supporting resistance to viral respiratory tract infections
07/05/2012US20120171163 Method for inhibiting a bacterial invasive mechanism using a nutritional composition
07/05/2012US20120171162 Fermented food products containing probiotic strains, and method for preparing same
07/05/2012US20120171161 Compositions comprising placental stem cells and platelet rich plasma, and methods of use thereof
07/05/2012US20120171159 Non-pathogenic and/or attenuated bacteria capable of inducing apoptosis in macrophages, process of manufacturing and uses thereof
07/05/2012US20120171156 Methods and compounds for reducing allergic reactions to hair dyes
07/05/2012CA2823601A1 Probiotic food suitable for salmonid fish species and the production thereof
07/05/2012CA2823540A1 Methods for cryopreserving and encapsulating cells
07/05/2012CA2823123A1 Ultrasonic cavitation derived stromal or mesenchymal vascular extracts and cells derived therefrom obtained from adipose tissue and use thereof
07/05/2012CA2823018A1 Use of nutritional compositions including lactoferrin in supporting resistance to diseases and conditions
07/05/2012CA2822892A1 Method for inhibiting pathogens using a nutritional composition
07/05/2012CA2822660A1 Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota
07/04/2012EP2471907A2 Placental stem cell populations
07/04/2012EP2471906A2 Placental stem cell populations
07/04/2012EP2471905A2 Placental stem cell populations
07/04/2012EP2471904A2 Placental stem cell populations
07/04/2012EP2471902A2 Production of artificial tissues by means of tissue engineering using agarose-fibrin biomaterials
07/04/2012EP2471544A1 Agent for reducing risk of developing cancer
07/04/2012EP2471543A1 Tolerance induction or immunosupression to prevent in particular Graft-versus-Host-Disease (GvHD) by short-term pre-incubation of transplanted cell suspensions, tissues or organs coated with ligands to cell surface molecules
07/04/2012EP2471542A1 Therapeutic agent for liver-related diseases
1 ... 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 ... 1259